{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T19:18:40Z","timestamp":1791314320711,"version":"4.3.1"},"reference-count":67,"publisher":"JLE","issue":"2","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["N\u00e9phrologie & Th\u00e9rapeutique"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1016\/j.nephro.2015.11.003","type":"journal-article","created":{"date-parts":[[2016,1,28]],"date-time":"2016-01-28T12:21:50Z","timestamp":1453983710000},"page":"76-85","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Infections \u00e0 BK virus en transplantation r\u00e9nale"],"prefix":"10.1684","volume":"12","author":[{"given":"Antoine","family":"Lanot","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6434-1259","authenticated-orcid":false,"given":"Nicolas","family":"Bouvier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Chatelet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Dina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cl\u00e9mence","family":"B\u00e9chade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxence","family":"Ficheux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Henri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Lobbedez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Hurault de Ligny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"18929","reference":[{"key":"10.1016\/j.nephro.2015.11.003_bib0340","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/S0140-6736(71)91776-4","article-title":"New human papovavirus (B.K.) isolated from urine after renal transplantation","volume":"1","author":"Gardner","year":"1971","journal-title":"Lancet"},{"key":"10.1016\/j.nephro.2015.11.003_bib0345","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/0272-6386(95)90608-8","article-title":"BK virus infection in a kidney allograft diagnosed by needle biopsy","volume":"26","author":"Purighalla","year":"1995","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.nephro.2015.11.003_bib0350","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1086\/597126","article-title":"Prevalence of polyomavirus BK and JC infection and replication in 400\u00a0healthy blood donors","volume":"199","author":"Egli","year":"2009","journal-title":"J Infect Dis"},{"key":"10.1016\/j.nephro.2015.11.003_bib0355","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1099\/vir.0.020115-0","article-title":"Prevalence and stability of antibodies to the BK and JC polyomaviruses: a long-term longitudinal study of Australians","volume":"91","author":"Antonsson","year":"2010","journal-title":"J Gen Virol"},{"key":"10.1016\/j.nephro.2015.11.003_bib0360","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1056\/NEJMoa020439","article-title":"Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients","volume":"347","author":"Hirsch","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nephro.2015.11.003_bib0365","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1111\/j.1600-6143.2005.00742.x","article-title":"Incidence of BK with Tacrolimus versus Cyclosporine and impact of preemptive immunosuppression reduction","volume":"5","author":"Brennan","year":"2005","journal-title":"Am J Transplant"},{"key":"10.1016\/j.nephro.2015.11.003_bib0370","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1097\/TP.0b013e31816a33d4","article-title":"Does reduction in immunosuppression in viremic patients prevent BK virus nephropathy in de novo renal transplant recipients?. A prospective study","volume":"85","author":"Alm\u00e9ras","year":"2008","journal-title":"Transplantation"},{"key":"10.1016\/j.nephro.2015.11.003_bib0375","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1097\/TP.0b013e31819cc383","article-title":"An OPTN analysis of national registry data on treatment of BK virus allograft nephropathy in the United States","volume":"87","author":"Dharnidharka","year":"2009","journal-title":"Transplantation"},{"key":"10.1016\/j.nephro.2015.11.003_bib0380","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1097\/TP.0b013e3181d0e15e","article-title":"Treatment of polyomavirus infection in kidney transplant recipients: a systematic review","volume":"89","author":"Johnston","year":"2010","journal-title":"Transplantation"},{"key":"10.1016\/j.nephro.2015.11.003_bib0385","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1097\/00007890-200204150-00013","article-title":"DNA sequencing of viral capsid protein VP-1\u00a0region in patients with BK virus interstitial nephritis","volume":"73","author":"Randhawa","year":"2002","journal-title":"Transplantation"},{"key":"10.1016\/j.nephro.2015.11.003_bib0390","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1053\/ajkd.2001.26101","article-title":"Molecular genotyping of BK and JC viruses in human polyomavirus-associated interstitial nephritis after renal transplantation","volume":"38","author":"Baksh","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.nephro.2015.11.003_bib0395","first-page":"172","article-title":"BK virus infection in transplant recipients: clinical manifestations, treatment options and the immune response","volume":"70","author":"Van Aalderen","year":"2012","journal-title":"Neth J Med"},{"key":"10.1016\/j.nephro.2015.11.003_bib0400","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/sj.ki.5000040","article-title":"BK virus nephritis after renal transplantation","volume":"69","author":"Hariharan","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.nephro.2015.11.003_bib0405","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nrneph.2011.59","article-title":"BK polyomavirus infection and nephropathy: the virus\u2013immune system interplay","volume":"7","author":"Babel","year":"2011","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.nephro.2015.11.003_bib0410","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.semcancer.2009.02.004","article-title":"BK virus and human cancer: innocent until proven guilty","volume":"19","author":"Abend","year":"2009","journal-title":"Seminars in Cancer Biology"},{"key":"10.1016\/j.nephro.2015.11.003_bib0415","series-title":"Fields virology.","first-page":"2263","article-title":"Polyomaviruses","author":"Imperiale","year":"2007"},{"key":"10.1016\/j.nephro.2015.11.003_bib0425","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1681\/ASN.2008010117","article-title":"Presence of urinary haufen accurately predicts polyomavirus nephropathy","volume":"20","author":"Singh","year":"2009","journal-title":"JASN"},{"key":"10.1016\/j.nephro.2015.11.003_bib0420","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/ajt.12110","article-title":"The AST Infectious Diseases Community of Practice. BK polyomavirus in solid organ transplantation","volume":"13","author":"Hirsch","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1016\/j.nephro.2015.11.003_bib0430","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1046\/j.1600-6143.2004.00603.x","article-title":"Histological patterns of polyomavirus nephropathy: correlation with graft outcome and viral load","volume":"4","author":"Drachenberg","year":"2004","journal-title":"Am J Transplant"},{"issue":"Suppl.\u00a05","key":"10.1016\/j.nephro.2015.11.003_bib0435","first-page":"C1354","article-title":"Detecting BK virus in the graft identifies positive BK viremia patients at high risk of developing BKVAN","volume":"13","author":"Sartorius","year":"2013","journal-title":"Am J Transplant"},{"issue":"Suppl.\u00a03","key":"10.1016\/j.nephro.2015.11.003_bib0440","first-page":"S1","article-title":"KDIGO clinical practice guideline for the care of kidney transplant recipients","volume":"9","author":"Kidney Disease: Improving Global Outcomes (KDIGO) Transplant Work Group","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1016\/j.nephro.2015.11.003_bib0445","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1111\/j.1432-2277.2012.01480.x","article-title":"Clinical usefulness of BK virus plasma quantitative PCR to prevent BK virus associated nephropathy","volume":"25","author":"Chung","year":"2012","journal-title":"Transplant Int"},{"key":"10.1016\/j.nephro.2015.11.003_bib0450","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1111\/j.1600-6143.2011.03693.x","article-title":"BK virus-specific immunity kinetics: a predictor of recovery from polyomavirus BK-associated nephropathy","volume":"11","author":"Schachtner","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1016\/j.nephro.2015.11.003_bib0455","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1111\/j.1600-6143.2010.03310.x","article-title":"Reducing immunosuppression preserves allograft function in presumptive and definitive polyomavirus-associated nephropathy","volume":"10","author":"Schaub","year":"2010","journal-title":"Am J Transplant"},{"key":"10.1016\/j.nephro.2015.11.003_bib0460","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1097\/TP.0b013e318197c17d","article-title":"The decade of polyomavirus BK-associated nephropathy: state of affairs","volume":"87","author":"Ramos","year":"2009","journal-title":"Transplantation"},{"key":"10.1016\/j.nephro.2015.11.003_bib0465","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1097\/TP.0b013e31826690c6","article-title":"Management and outcome of BK viremia in renal transplant recipients: a prospective single-center study","volume":"94","author":"Sood","year":"2012","journal-title":"Transplantation"},{"key":"10.1016\/j.nephro.2015.11.003_bib0470","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1097\/TP.0b013e318166cba8","article-title":"Successful treatment of BK viremia using reduction in immunosuppression without antiviral therapy","volume":"85","author":"Saad","year":"2008","journal-title":"Transplantation"},{"key":"10.1016\/j.nephro.2015.11.003_bib0475","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1097\/TP.0b013e31825a505d","article-title":"Factors influencing viral clearing and renal function during polyomavirus BK-associated nephropathy after renal transplantation","volume":"94","author":"Schwarz","year":"2012","journal-title":"Transplantation"},{"key":"10.1016\/j.nephro.2015.11.003_bib0480","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/j.1600-6143.2012.04320.x","article-title":"replication in de novo kidney transplant patients receiving tacrolimus or cyclosporine: a prospective, randomized, multicenter study","volume":"13","author":"Hirsch","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1016\/j.nephro.2015.11.003_bib0485","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1097\/TP.0b013e3181bca422","article-title":"Inhibition of polyomavirus BK-specific T-Cell responses by immunosuppressive drugs","volume":"88","author":"Egli","year":"2009","journal-title":"Transplantation"},{"key":"10.1016\/j.nephro.2015.11.003_bib0490","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1111\/j.1523-1755.2005.00602.x","article-title":"BK virus nephritis: risk factors, timing, and outcome in renal transplant recipients","volume":"68","author":"Vasudev","year":"2005","journal-title":"Kidney Int"},{"key":"10.1016\/j.nephro.2015.11.003_bib0495","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.2215\/CJN.05691207","article-title":"Aggressive immunosuppression minimization reduces graft loss following diagnosis of BK virus-associated nephropathy: a comparison of two reduction strategies","volume":"3","author":"Weiss","year":"2008","journal-title":"CJASN"},{"key":"10.1016\/j.nephro.2015.11.003_bib0500","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1681\/ASN.2014010119","article-title":"Persistent BK viremia does not increase intermediate-term graft loss but is associated with de novo donor-specific antibodies","volume":"26","author":"Sawinski","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.nephro.2015.11.003_bib0505","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1111\/ajt.12218","article-title":"Pathology of resolving polyomavirus-associated nephropathy","volume":"13","author":"Menter","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1016\/j.nephro.2015.11.003_bib0510","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1097\/00007890-200202150-00008","article-title":"Experiences with leflunomide in solid organ transplantation","volume":"73","author":"Williams","year":"2002","journal-title":"Transplantation"},{"key":"10.1016\/j.nephro.2015.11.003_bib0515","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1097\/01.tp.0000181149.76113.50","article-title":"Treatment of renal allograft polyoma BK virus infection with leflunomide","volume":"81","author":"Josephson","year":"2006","journal-title":"Transplantation"},{"key":"10.1016\/j.nephro.2015.11.003_bib0520","doi-asserted-by":"crossref","first-page":"829","DOI":"10.2215\/CJN.03930907","article-title":"Higher levels of leflunomide are associated with hemolysis and are not superior to lower levels for BK virus clearance in renal transplant patients","volume":"3","author":"Leca","year":"2008","journal-title":"CJASN"},{"key":"10.1016\/j.nephro.2015.11.003_bib0525","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.2215\/CJN.12531211","article-title":"Leflunomide efficacy and pharmacodynamics for the treatment of BK viral infection","volume":"7","author":"Krisl","year":"2012","journal-title":"CJASN"},{"key":"10.1016\/j.nephro.2015.11.003_bib0530","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1097\/TP.0b013e3182007be2","article-title":"Anti-BK virus mechanisms of sirolimus and leflunomide alone and in combination: toward a new therapy for BK virus infection","volume":"90","author":"Liacini","year":"2010","journal-title":"Transplantation"},{"key":"10.1016\/j.nephro.2015.11.003_bib0535","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.antiviral.2011.07.012","article-title":"Fluoroquinolones inhibit human polyomavirus BK (BKV) replication in primary human kidney cells","volume":"92","author":"Sharma","year":"2011","journal-title":"Antiviral Res"},{"key":"10.1016\/j.nephro.2015.11.003_bib0540","doi-asserted-by":"crossref","first-page":"583","DOI":"10.2215\/CJN.04230413","article-title":"Efficacy of levofloxacin in the treatment of BK viremia: a multicenter, double-blinded, randomized, placebo-controlled trial","volume":"9","author":"Lee","year":"2014","journal-title":"CJASN"},{"key":"10.1016\/j.nephro.2015.11.003_bib0545","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1093\/jac\/dkn495","article-title":"A single-centre study of adjuvant cidofovir therapy for BK virus interstitial nephritis (BKVIN) in renal allograft recipients","volume":"63","author":"Kuypers","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.nephro.2015.11.003_bib0550","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1111\/j.1600-6143.2008.02269.x","article-title":"Cidofovir inhibits polyomavirus BK replication in human renal tubular cells downstream of viral early gene expression","volume":"8","author":"Bernhoff","year":"2008","journal-title":"Am J Transplant"},{"key":"10.1016\/j.nephro.2015.11.003_bib0555","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1056\/NEJMoa1303688","article-title":"CMX001-201\u00a0Clinical Study Group. CMX001\u00a0to prevent cytomegalovirus disease in hematopoietic-cell transplantation","volume":"369","author":"Marty","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nephro.2015.11.003_bib0560","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1128\/AAC.01241-07","article-title":"Anti-BK virus activity of nucleoside analogs","volume":"52","author":"Randhawa","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.nephro.2015.11.003_bib0565","doi-asserted-by":"crossref","first-page":"A84","DOI":"10.1016\/j.antiviral.2009.01.005","article-title":"Alkoxyalkyl prodrugs of acyclic nucleoside phosphonates enhance oral antiviral activity and reduce toxicity: current state of the art","volume":"82","author":"Hostetler","year":"2009","journal-title":"Antiviral Res"},{"key":"10.1016\/j.nephro.2015.11.003_bib0570","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1111\/apm.12134","article-title":"The human polyomavirus BK (BKPyV): virological background and clinical implications","volume":"121","author":"Rinaldo","year":"2013","journal-title":"APMIS"},{"key":"10.1016\/j.nephro.2015.11.003_bib0575","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1097\/TP.0b013e3181daaaf1","article-title":"Polyomavirus BK neutralizing activity in human immunoglobulin preparations","volume":"89","author":"Randhawa","year":"2010","journal-title":"Transplantation"},{"key":"10.1016\/j.nephro.2015.11.003_bib0580","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1111\/ajt.13083","article-title":"Commercially available immunoglobulins contain virus neutralizing antibodies against all major genotypes of polyomavirus BK","volume":"15","author":"Randhawa","year":"2015","journal-title":"Am J Transplant"},{"key":"10.1016\/j.nephro.2015.11.003_bib0585","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/01.tp.0000181096.14257.c2","article-title":"Intravenous immunoglobulin as a treatment for BK virus associated nephropathy: one-year follow-up of renal allograft recipients","volume":"81","author":"Sener","year":"2006","journal-title":"Transplantation"},{"key":"10.1016\/j.nephro.2015.11.003_bib0590","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.trre.2011.05.002","article-title":"The influence of immunosuppressive agents on BK virus risk following kidney transplantation, and implications for choice of regimen","volume":"26","author":"Suwelack","year":"2012","journal-title":"Transplant Rev"},{"key":"10.1016\/j.nephro.2015.11.003_bib0595","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1111\/j.1432-2277.2009.00842.x","article-title":"Treatment for BK virus: incidence, risk factors and outcomes for kidney transplant recipients in the United States","volume":"22","author":"Schold","year":"2009","journal-title":"Transpl Int"},{"key":"10.1016\/j.nephro.2015.11.003_bib0600","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/tid.12051","article-title":"Ureteral stent placement and BK viremia in kidney transplant recipients","volume":"15","author":"Kayler","year":"2013","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.nephro.2015.11.003_bib0605","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1097\/TP.0b013e3182921995","article-title":"Risk factors for BK virus infection in the era of therapeutic drug monitoring","volume":"95","author":"Borni-Duval","year":"2013","journal-title":"Transplantation"},{"key":"10.1016\/j.nephro.2015.11.003_bib0610","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.nephro.2014.07.282","article-title":"\u00c9tude des facteurs de risque de BK virurie significative au cours des trois premiers mois de transplantation r\u00e9nale [r\u00e9sum\u00e9]","volume":"10","author":"Lamy","year":"2014","journal-title":"Nephrol Ther"},{"key":"10.1016\/j.nephro.2015.11.003_bib0615","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/TP.0b013e3181c9b51c","article-title":"A suppressive effect of cyclosporine\u00a0A on replication and noncoding control region activation of polyomavirus BK virus","volume":"89","author":"Li","year":"2010","journal-title":"Transplantation"},{"key":"10.1016\/j.nephro.2015.11.003_bib0620","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/TP.0b013e3181927a41","article-title":"Conversion from calcineurin inhibitors to sirolimus maintenance therapy in renal allograft recipients: 24-month efficacy and safety results from the CONVERT trial","volume":"87","author":"Schena","year":"2009","journal-title":"Transplantation"},{"key":"10.1016\/j.nephro.2015.11.003_bib0625","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/tid.12347","article-title":"Conversion to a sirolimus-based regimen is associated with lower incidence of BK viremia in low-risk kidney transplant recipients","volume":"17","author":"Tohme","year":"2015","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.nephro.2015.11.003_bib0630","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/01.tp.0000268524.27506.39","article-title":"BK virus-associated nephropathy in sirolimus-treated renal transplant patients: incidence, course, and clinical outcomes","volume":"84","author":"Benavides","year":"2007","journal-title":"Transplantation"},{"key":"10.1016\/j.nephro.2015.11.003_bib0635","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1097\/TP.0b013e3182848e03","article-title":"Randomized trial of everolimus-facilitated calcineurin inhibitor minimization over 24\u00a0months in renal transplantation","volume":"95","author":"Cibrik","year":"2013","journal-title":"Transplantation"},{"key":"10.1016\/j.nephro.2015.11.003_bib0640","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1111\/ctr.12151","article-title":"Everolimus leads to a lower risk of BKV viremia than mycophenolic acid in de novo renal transplantation patients: a single-center experience","volume":"27","author":"Moscarelli","year":"2013","journal-title":"Clin Transplant"},{"key":"10.1016\/j.nephro.2015.11.003_bib0645","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.2215\/CJN.08261109","article-title":"Evaluation of fluoroquinolones for the prevention of BK viremia after renal transplantation","volume":"5","author":"Gabardi","year":"2010","journal-title":"CJASN"},{"key":"10.1016\/j.nephro.2015.11.003_bib0650","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1001\/jama.2014.14721","article-title":"Levofloxacin for BK virus prophylaxis following kidney transplantation: a randomized clinical trial","volume":"312","author":"Knoll","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.nephro.2015.11.003_bib0655","first-page":"ID459747","article-title":"Ureteral stent placement increases the risk for developing BK viremia after kidney transplantation","author":"Hashim","year":"2014","journal-title":"J Transplant"},{"key":"10.1016\/j.nephro.2015.11.003_bib0660","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1097\/TP.0b013e3181643b6f","article-title":"Ureteral placement and BK virus allograft nephropathy in renal transplant recipients","volume":"85","author":"Kazory","year":"2008","journal-title":"Transplantation"},{"key":"10.1016\/j.nephro.2015.11.003_bib0665","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1111\/j.1600-6143.2010.03083.x","article-title":"Retransplantation after BK virus nephropathy in prior kidney transplant: an OPTN database analysis","volume":"10","author":"Dharnidharka","year":"2010","journal-title":"Am J Transplant"},{"key":"10.1016\/j.nephro.2015.11.003_bib0335","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1097\/TP.0b013e31822d08c1","article-title":"Results of repeat renal transplantation after graft loss from BK virus nephropathy","volume":"92","author":"Geetha","year":"2011","journal-title":"Transplant"}],"container-title":["N\u00e9phrologie & Th\u00e9rapeutique"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1769725515006884?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1769725515006884?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.jle.com\/10.1016\/j.nephro.2015.11.003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T16:23:11Z","timestamp":1741191791000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1769725515006884"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":67,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["S1769725515006884"],"URL":"https:\/\/doi.org\/10.1016\/j.nephro.2015.11.003","relation":{},"ISSN":["1769-7255"],"issn-type":[{"value":"1769-7255","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Infections \u00e0 BK virus en transplantation r\u00e9nale","name":"articletitle","label":"Article Title"},{"value":"N\u00e9phrologie & Th\u00e9rapeutique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nephro.2015.11.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Association Soci\u00e9t\u00e9 de n\u00e9phrologie. Published by Elsevier Masson SAS All rights reserved.","name":"copyright","label":"Copyright"}]}}